Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 3
2006 4
2007 1
2008 3
2009 2
2010 3
2011 5
2012 2
2013 1
2014 3
2015 2
2016 4
2017 3
2018 3
2019 6
2020 6
2021 4
2022 2
2023 8
2024 5
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for venisse n
Search for Veisse N instead (2 results)
[Therapeutic drug monitoring].
Le Guellec C, Bentué-Ferrer D; groupe STP de la SFPT. Le Guellec C, et al. Therapie. 2010 Jan-Feb;65(1):13-5. Therapie. 2010. PMID: 20443240 French. No abstract available.
L-serine promotes pro-carcinogenic effects of colibactin-producing E. coli.
Devaux A, Villéger R, Roche G, Diémé B, Rodrigues M, Juban C, Lagrée M, Venisse N, Jousse C, Barnich N, Bonnet M. Devaux A, et al. Among authors: venisse n. Gut Microbes. 2025 Dec;17(1):2515480. doi: 10.1080/19490976.2025.2515480. Epub 2025 Jun 5. Gut Microbes. 2025. PMID: 40471070 Free PMC article.
BPA and risk assessment.
Dupuis A, Rabouan S, Migeot V, Venisse N. Dupuis A, et al. Among authors: venisse n. Lancet Diabetes Endocrinol. 2020 Apr;8(4):270-271. doi: 10.1016/S2213-8587(20)30069-3. Lancet Diabetes Endocrinol. 2020. PMID: 32197111 No abstract available.
Niveau de preuve du suivi thérapeutique pharmacologique de la teicoplanine.
Boulamery A, Venisse N, Le Guellec C; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Boulamery A, et al. Among authors: venisse n. Therapie. 2011 Jan-Feb;66(1):45-50. doi: 10.2515/therapie/2011003. Therapie. 2011. PMID: 27393464 French.
Niveau de preuve du suivi thérapeutique pharmacologique des aminosides.
Venisse N, Boulamery A; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Venisse N, et al. Therapie. 2011 Jan-Feb;66(1):39-44. doi: 10.2515/therapie/2011001. Therapie. 2011. PMID: 27393463 French.
Trends in fatal poisoning among medical users of analgesics in France from 2013 to 2022: an analysis of the DTA register.
Revol B, Willeman T, Manceau M, Dumestre-Toulet V, Gaulier JM, Eysseric-Guérin H, Fouilhé Sam-Laï N; Compagnie Nationale des Biologistes et Analystes Experts (CNBAE), and the French Addictovigilance Network (FAN). Revol B, et al. Public Health. 2024 Nov;236:381-385. doi: 10.1016/j.puhe.2024.08.019. Epub 2024 Sep 19. Public Health. 2024. PMID: 39303626 Free article.
Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.
Benaboud S, Solas C, Bouchet S, Gregoire M, Lemaitre F, Venisse N, Lê MP, Muret P, Parant F, Neant N, Boujafaar S, Lagoutte-Renosi J, Garraffo R, Peytavin G. Benaboud S, et al. Among authors: venisse n. J Antimicrob Chemother. 2023 Mar 2;78(3):853-854. doi: 10.1093/jac/dkad009. J Antimicrob Chemother. 2023. PMID: 36683308 No abstract available.
N-Ethylhexedrone: A very long and bad trip! A case series.
Lefeuvre S, Richeval C, Lelong J, Venisse N, Humbert L, Brunet B. Lefeuvre S, et al. Among authors: venisse n. J Anal Toxicol. 2024 Aug 21;48(7):507-513. doi: 10.1093/jat/bkae040. J Anal Toxicol. 2024. PMID: 38794952
64 results